Jeff Geschwind, MD – Cancer Drug Development Expert As founder of Cage Pharma, Jeff Geschwind, MD focuses on glycolysis-targeting cancer drugs, disrupting tumor metabolism. His innovative approach opens new possibilities for treating aggressive cancers with fewer side effects. https://www.linkedin.com/in/jeff-geschwind-037200174